Skip to main content
Premium Trial:

Request an Annual Quote

CIA-Founded Non-Profit Invests in OpGen to Develop Microbial-Analysis Tech

NEW YORK (GenomeWeb News) — Microbial genomics company OpGen today said it has received an undisclosed investment from In-Q-Tel, a non-profit launched by the US Central Intelligence Agency that invests in technologies "of importance to the intelligence community."
 
In a statement describing the investment, In-Q-Tel said that OpGen’s microbial genome-analysis technology will “significantly improve the user's ability to analyze organisms.”
 
The investment fits OpGen’s “move towards delivering stand-alone instruments and disposables for microbial analysis,” OpGen CSO Colin Dykes said in the statement.
 
The investment comes one month after OpGen closed a Series A funding round worth $23.6 million.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.